China Gold International Resources (CGG)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 32.94 |
|---|---|
| 52-week range | 21.28 – 48.99 |
| Return, 1 month / 3 months | −19.3% / +10.6% |
| Return, 1 year / 3 years | +46.6% / +490.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 28 |
| Volatility (1 year) | 64.3% |
| Worst drawdown (1 year) | -49.1% |
| Average daily value traded | 3.76M CAD |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Gold International Resources is a mining company that produces gold and copper concentrates. Its operations include a gold mine in Inner Mongolia and a copper-gold polymetallic mine in Tibet, where it extracts ore and processes it into saleable concentrate. The company's customers are mainly smelters and metal traders that refine the concentrates further. It is based in Canada and is associated with China National Gold Group, a state-owned Chinese mining enterprise.
On this site China Gold International Resources appears as a stock on the Toronto Exchange (Canada), code CGG, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Gold International Resources (CGG) trades on the Toronto Exchange in Canada. It last closed at CAD 32.94 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 407 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 46.6% and over the last three months it rose 10.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.3% | ||
| From 52-week high | -31.9% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.6% | ||
| 6-month return | 10.7% | ||
| 12-month return, skipping the last month | 81.5% | ||
| Stability (higher is calmer) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 64.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.1% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.76M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 4 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −14.5% |
|---|---|
| 1 month | −19.3% |
| 3 months | +10.6% |
| 6 months | +10.7% |
| 1 year | +46.6% |
| 3 years | +490.7% |
| 5 years | +921.7% |
Signals
| 50-day / 200-day average | 41.86 / 32.84 |
|---|---|
| Golden / death cross (60 days) | Golden, 44 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.65 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | CAD 0.6420 |
| 23 Apr 2025 | CAD 0.1110 |
| 19 Apr 2023 | CAD 0.4950 |
| 19 Apr 2022 | CAD 0.3150 |
| 19 Apr 2021 | CAD 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.